TR199800801T2 - Travmatik beyin yaralanmalar�n�n tedavisi. - Google Patents

Travmatik beyin yaralanmalar�n�n tedavisi.

Info

Publication number
TR199800801T2
TR199800801T2 TR1998/00801T TR9800801T TR199800801T2 TR 199800801 T2 TR199800801 T2 TR 199800801T2 TR 1998/00801 T TR1998/00801 T TR 1998/00801T TR 9800801 T TR9800801 T TR 9800801T TR 199800801 T2 TR199800801 T2 TR 199800801T2
Authority
TR
Turkey
Prior art keywords
traumatic brain
treatment
brain injuries
injuries
injury
Prior art date
Application number
TR1998/00801T
Other languages
English (en)
Turkish (tr)
Inventor
R. Pike Brian
Original Assignee
H. Lund-Beck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lund-Beck A/S filed Critical H. Lund-Beck A/S
Publication of TR199800801T2 publication Critical patent/TR199800801T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TR1998/00801T 1995-11-06 1996-11-05 Travmatik beyin yaralanmalar�n�n tedavisi. TR199800801T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06

Publications (1)

Publication Number Publication Date
TR199800801T2 true TR199800801T2 (xx) 1998-08-21

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00801T TR199800801T2 (xx) 1995-11-06 1996-11-05 Travmatik beyin yaralanmalar�n�n tedavisi.

Country Status (18)

Country Link
EP (1) EP0866706A1 (xx)
JP (1) JPH11514654A (xx)
KR (1) KR19990067353A (xx)
AU (1) AU706594B2 (xx)
BG (1) BG63150B1 (xx)
BR (1) BR9611396A (xx)
CA (1) CA2234824A1 (xx)
CZ (1) CZ287441B6 (xx)
EA (1) EA000531B1 (xx)
HU (1) HUP9901051A2 (xx)
IS (1) IS4726A (xx)
NO (1) NO982036L (xx)
NZ (1) NZ321546A (xx)
PL (1) PL326490A1 (xx)
SK (1) SK58198A3 (xx)
TR (1) TR199800801T2 (xx)
WO (1) WO1997017074A1 (xx)
ZA (1) ZA969320B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
BG102480A (en) 1999-01-29
EP0866706A1 (en) 1998-09-30
PL326490A1 (en) 1998-09-28
BR9611396A (pt) 1999-07-13
AU7490096A (en) 1997-05-29
CA2234824A1 (en) 1997-05-15
EA000531B1 (ru) 1999-10-28
EA199800434A1 (ru) 1998-10-29
NO982036D0 (no) 1998-05-05
JPH11514654A (ja) 1999-12-14
CZ138998A3 (cs) 1998-10-14
AU706594B2 (en) 1999-06-17
IS4726A (is) 1998-04-27
NZ321546A (en) 2000-12-22
MX9803432A (es) 1998-09-30
NO982036L (no) 1998-06-25
SK58198A3 (en) 1998-10-07
WO1997017074A1 (en) 1997-05-15
CZ287441B6 (en) 2000-11-15
KR19990067353A (ko) 1999-08-16
ZA969320B (en) 1997-05-30
BG63150B1 (bg) 2001-05-31
HUP9901051A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
NL300140I1 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
NO871549D0 (no) Medikament for behandling av oeyenbetennelser.
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
FI964771A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
TR199800801T2 (xx) Travmatik beyin yaralanmalar�n�n tedavisi.
DK0562705T3 (da) Anvendelse af L-deprenyl til fremstilling af et lægemiddel til behandling af Cushings sygdom
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
DK0578477T3 (da) Behandling af inflammatorisk tarmsygdom
ATE137223T1 (de) Leukotrien-b4-antagonisten
FR2689017B1 (fr) Appareil d'injection medicale ou veterinaire.
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DE69419954T2 (de) Arzneimittel zur Behandlung von Hauterkrankungen
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DE69334087D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE69327074D1 (de) Substituierte 1,2,4-Triazine-3,5-Dion Derivate und diese enthaltende Arzneimittel, insbesondere zur Behandlung von Coccidiose
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen